Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 1,698

Document Document Title
WO/2017/203516A1
The present invention relates to a method for total chemical synthesis of 9-cis-β-carotene (9CBC), and further provides stable formulations thereof.  
WO/2017/162413A1
The invention relates to solid, at least triple-phase active substance preparations, in which two separate phases are embedded in a multiparticulate manner into a coherent active substance and antioxidant-free phase, one of said embedded...  
WO/2017/142854A1
A method of producing positively charged liposome vesicles for use as carriers of lipophilic molecules. A mixture of hydrogenated phospholipids, a cationic excipient and a lipophilic molecule are dissolved in a solvent to form a composit...  
WO/2017/125379A1
The present invention relates to process for the maintaining of a ratio stereoisomers of carotenoid compounds by using of at least one alkali hydroxide and/or earth alkali hydroxide, to specific formulations and to the use of such specif...  
WO/2017/111761A1
The present invention relates to a process for producing carotenoid extract from a carotenoid source, the process comprising: providing a carotenoid source; providing an extraction solvent including at least one acetal compound and at le...  
WO/2017/100915A1
There is provided an improved extraction process for obtaining integral & active thylakoid membranes that have longer shelf-life at room temperature. Particularly, the extract is lyophilized in a solution of PVP and remains stable with a...  
WO/2017/099443A1
The present invention relates to a retinoid compound containing dopamine and a method for preparing the same and, more specifically, to a retinoid compound containing dopamine which can bind dopamine to retinoic acid so as to improve the...  
WO/2017/099662A1
A method for producing derivatives of N-retinoylaminoalkane sulfonic acid, the method comprising providing retinoic acid, chloroformate, aminoalkanesulfonic acid selected from the group consisting of cysteic acidand alkyl ester thereof, ...  
WO/2017/084493A1
Disclosed is a method for removing benzo[α]pyrene from a liposoluble natural extract. The method of the present invention comprises adding a suitable solvent to a crude natural extract product so as to obtain a mixed material; heating t...  
WO/2017/083351A1
Non-naturally occurring microorganisms are provided that produce taurine and/or taurine precursors, e.g., hypotaurine, sulfoacetaldehyde, or cysteate, utilizing exogenously added enzyme activities. Methods of producing taurine and/or tau...  
WO/2017/075698A1
There is provided the use of a functional thylakoid extract, particularly in admixture with a physiologically acceptable carrier, in pharmaceutical application, in the treatment of inflammatory bowel disease, and method for the treatment...  
WO/2017/049110A1
Compounds having inhibitory activity against retinaldehyde dehydrogenases (RALDHs). The compounds can be used, for example, to inhibit synthesis of retinoic acid for the treatment of refractive error disorders such as myopia, and as infe...  
WO/2017/029313A1
The present invention relates to a process for preparing 1-(2,6,6-trimethylcyclohex-2- en-1-yl)but-2-en-1-one, which comprises a) providing 6,10-dimethylundeca-1,5,9-trien-4-ol, b) oxidizing 6,10-dimethylundeca-1,5,9-trien-4-ol provided ...  
WO/2017/019556A1
Embodiments of the present disclosure generally relate to compositions, methods and systems for the isolation and separation of undesirable products from desirable products in biomass extracts. In certain embodiments, the present disclos...  
WO/2016/207199A1
The present invention is directed to a process for the manufacture of a formulation of β-carotene, wherein the β-carotene is embedded in a matrix of at least one modified food starch, and wherein the β-carotene in said formulation has...  
WO/2016/202125A1
Disclosed are an intermediate, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-forma midine]phenyl-2-propenamide (II), applicable in preparing AZD9291 (I) and a preparation method for the intermediate. Preparation steps comprise: ...  
WO/2016/181288A1
The retinoid X receptors (RXRs) are ligand-activated transcription factors heterodimerize with a number of nuclear hormone receptors, thereby controlling a variety of physiological processes. The invention relates to novel enantiomer com...  
WO/2016/175670A1
The present invention discloses a process of isolation and purification of diatoxanthin and diadinoxanthin, which consists of five steps including: diatoms cultivation, pigment extraction, pigment partitioning, silica gel alkalization, o...  
WO/2016/151552A3
Methods herein are described for improvement in visual function by administering macular carotenoid compositions containing an effective daily dose, to a subject in need thereof. More particularly, methods herein are described and includ...  
WO/2016/146802A1
The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. Astaxanthin compositions, which contain at least 80 wt.%, in particular at least 90 wt.%, especially at least 95 wt.%...  
WO/2016/146804A1
The invention relates to astaxanthin compositions for use in foods, food supplements or animal feed or as a medicament. (Formula (A)) Astaxanthin compositions, which contain at least 50 wt.%, in particular at least 60 wt.%, more particul...  
WO/2016/124783A1
The invention relates to a microcapsule comprising at least one active substance selected from lutein and lutein esters embedded in a matrix comprising porcine gelatine or bovine gelatine and optionally one or more other matrix component...  
WO/2016/124784A1
The invention relates to microcapsules comprising at least one active substance selected from lutein and lutein esters embedded in a matrix comprising gum acacia and optionally one or more other matrix components, wherein the content of ...  
WO/2016/100972A3
Iontophoresis, a minimally-invasive methodology that uses a weak electric current to enhance penetration of ionized molecules into tissues, was found to be an effective technique for the intraocular delivery of large bioactive molecules,...  
WO/2016/100972A4
Iontophoresis, a minimally-invasive methodology that uses a weak electric current to enhance penetration of ionized molecules into tissues, was found to be an effective technique for the intraocular delivery of large bioactive molecules,...  
WO/2016/079103A1
The present invention relates to a process for the preparation of 1-(2,6,6- trimethylcyclohexyl)-alkan-3-ols, in particular 1-(2,6,6-trimethylcyclohexyl)-hexan-3-ol. The invention further relates to 5-alkoxy-1-(2,6,6-trimethylcyclohexeny...  
WO/2016/076454A1
The present invention relates to a method for producing 9-cis β-carotene from microorganisms, comprising a method for improving the culture rate of microorganisms using a photochemical gas generated by the micro-spray of gas and the con...  
WO/2016/063278A1
The present disclosure provides a polymer having a repeating unit comprising at least one astaxanthin moiety, including processes for its preparation and various uses thereof.  
WO/2016/059151A1
The present invention relates to a catalytic process for the ethynylation of specific poly- unsaturated aldehydes and ketones.  
WO/2016/059150A1
The present invention relates to a new method to produce 7,8-dihydro-C15- aldehyde.  
WO/2016/050909A1
The present invention relates to a process for purifying the xanthophylls astaxanthin and canthaxanthin. The process comprises suspending the xanthophyll in an organic solvent or solvent mixture, treating the suspension of the xanthophyl...  
WO/2016/047532A1
A compound represented by formula (IV) or a salt thereof has an inhibitory effect on abscisic acid receptors. The compound or a salt thereof can be used as a plant growth regulator. [X is an ethylene group, an ethenylene group or an ethy...  
WO/2016/037785A1
The invention relates to an environmentally friendly, resource-conserving, and economical method for producing astaxanthin esters of formula 1, wherein astaxanthin of formula 2 is doubly esterified with fatty acid chlorides of general fo...  
WO/2016/023772A1
The invention relates to a process for preparing a cyclic alpha-keto alcohol, especially a 6-hydroxycyclohexenone of the formula 1a or 1b, from a cyclic alpha-keto enol, especially a 6-hydroxycyclohexadienone of the formula 2a or 2b, usi...  
WO/2016/023732A1
The invention relates to a method for the non-stereoselective and for the stereoselective synthesis of astaxanthin from astacin. For this purpose, a reductant is used, which is selected from the group of hydrogen gas, a secondary alcohol...  
WO/2015/178404A1
The present invention addresses the problem of discovering a carotenoid compound exhibiting excellent water solubility. Provided is a carotenoid derivative represented by general formula (I) [in general formula (I): X represents a carbon...  
WO/2015/175479A1
This invention relates to pharmaceutical compositions for oral administration to treat, for example, acute radiation sickness, wherein the composition comprises, for example, a first agent which is selected from the group consisting of b...  
WO/2015/144831A1
The present invention relates to an improved process for isolating a carotenoid from a carotenoid-producing bioorganism, as well as to a formulation comprising such a carotenoid, and the use of such a solid formulation in feed products (...  
WO/2015/109657A1
The present invention provides a method for manufacturing nature zeaxanthin by means of in-situ concentration. Specifically, the method comprises: preparing nature zeaxanthin from a plant by using extraction and saponification , performi...  
WO/2015/097717A3
The present invention relates to an improved process for the preparation of β-carotene having pharmaceutically acceptable level of residual solvent content.  
WO/2015/067711A1
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where methanol is used to drastically reduce the content of dichloromethane in suc...  
WO/2015/067705A1
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where methanol is used to drastically reduce the content of dichloromethane in suc...  
WO/2015/067706A1
The present invention is directed to a process for the manufacture of synthetic food-grade astaxanthin with a content of dichloromethane ≤ 250 ppm comprising the following steps: a) Providing synthetic astaxanthin crystals containing d...  
WO/2015/067707A1
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where ethyl acetate is used to drastically reduce the content of dichloromethane a...  
WO/2015/067709A1
The present invention is directed to synthetic astaxanthin which is suitable for human consumption. The present invention is further directed to processes where an alkanol selected from the group consisting of methanol, ethanol, 1-propan...  
WO/2015/059696A1
The invention provides a process for the preparation of alkyl 4-methyl-6-(2,6,6-trimethylcyclohex-lenyl) hex-3-enoate comprising a single step wherein 2-methyl-4-(2,6,6- trimethylcyclohex-l-en-l-yl)butanal is reacted with monoalkyl malon...  
WO/2015/043112A1
A high-content carotenoid compound from adonis amurensis. The content of the total carotenoid of the carotenoid compound is higher than 95%. The content of all-trans (3S, 3'S)-carotenoid is higher than 80%. The carotenoid crystals have a...  
WO/2015/028132A1
An aqueous emulsion for use in veterinary medicine which contains beta carotene and can be administered parenterally from a sterile multi-dose container contains acetylcysteine in an amount of between 1 and 8 wt.-% as a substance which s...  
WO/2015/009174A1
The invention relates to an oxidation process for producing astaxanthin from meso-zeaxanthin using o-iodoxybenzoic acid as an oxidant.  
WO/2014/202677A1
The present invention relates to process for the maintaining of a ratio stereoisomers of carotenoid compounds by using at least one alkali and/or earth alkali metal salt of an organic acid, to specific formulations and to the use of such...  

Matches 1 - 50 out of 1,698